Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     
  • Bitcoin CAD

    87,478.44
    -775.20 (-0.88%)
     
  • CMC Crypto 200

    1,386.99
    +4.41 (+0.32%)
     
  • GOLD FUTURES

    2,341.90
    -0.60 (-0.03%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,755.75
    +188.25 (+1.07%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,614.60
    -13.88 (-0.04%)
     
  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Company News for Jul 21, 2021

  • Shares of HCA Healthcare, Inc. HCA surged 14.4% after the company reported second-quarter 2021 adjusted earnings of $4.37 per share, surpassing the Zacks Consensus Estimate of $3.17 per share.

  • Synchrony Financial’s SYF shares gained 2.7% after the company reported second-quarter 2021 earnings of $2.12 per share, outpacing the Zacks Consensus Estimate of $1.47 per share.

  • Shares of Citizens Financial Group, Inc. CFG increased 3.6% after it reported second-quarter 2021 adjusted earnings of $1.46 per share, surpassing the Zacks Consensus Estimate of $1.14 per share.

  • Dover Corporation’s DOV shares soared 6.7% after the company reported second-quarter 2021 adjusted earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.84 per share.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Dover Corporation (DOV) : Free Stock Analysis Report
 
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
 
Synchrony Financial (SYF) : Free Stock Analysis Report
 
Citizens Financial Group, Inc. (CFG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research